• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡泊三醇/倍他米松二丙酸酯泡沫组合的短期和长期疗效

Short Term and Long-Term Efficacy of Calcipotriene/ Betamethasone Dipropionate Foam Combination.

作者信息

Jalili Ahmad, Bewley Anthony, Sticherling Michael, Stein Gold Linda

机构信息

Dermatology & Skin Care Clinic, Buochs, Switzerland.

Barts Health NHS Trust and Queen Mary University London, London, UK.

出版信息

Clin Cosmet Investig Dermatol. 2022 May 2;15:809-814. doi: 10.2147/CCID.S361884. eCollection 2022.

DOI:10.2147/CCID.S361884
PMID:35531463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075015/
Abstract

Psoriasis is a well-known chronic disease characterized by the development of erythematous, indurated, scaly, pruritic plaques on the skin with cycles of remission and symptom flare-ups. The management of patients with chronic plaque psoriasis has been more challenging since the Covid-19 pandemic as health care professionals have had to adapt to remote consultations for some patients, and patients have had to adapt to the changing health landscape. The rapid resolution of psoriasis symptoms especially those with a substantial impact on quality of life can improve patient satisfaction and adherence, making it an important factor in successful treatment. Cal/BD foam contributes to improved patient adherence and treatment outcome through its rapid action and superior efficacy versus Cal or BD monotherapy, Cal/BD ointment and gel and clobetasol cream in the short-term flare treatment of psoriasis. Moreover, the benefits of proactive long-term management of psoriasis compared to reactive management and its favourable safety profile are higher efficacy and a better health-related quality of life. Cal/BD foam should be considered an effective topical treatment for short-term flare treatment and long-term control of adult psoriatic patients.

摘要

银屑病是一种众所周知的慢性疾病,其特征是皮肤上出现红斑、硬结、鳞屑、瘙痒性斑块,并伴有缓解期和症状复发周期。自新冠疫情以来,慢性斑块状银屑病患者的管理变得更具挑战性,因为医护人员不得不适应对部分患者进行远程会诊,而患者也不得不适应不断变化的健康状况。银屑病症状的快速缓解,尤其是那些对生活质量有重大影响的症状的缓解,可以提高患者满意度和依从性,这使其成为成功治疗的一个重要因素。在银屑病短期发作治疗中,与钙泊三醇或倍他米松单药治疗、钙泊三醇/倍他米松软膏和凝胶以及丙酸氯倍他索乳膏相比,钙泊三醇/倍他米松泡沫剂因其快速起效和卓越疗效,有助于提高患者依从性和治疗效果。此外,与被动管理相比,银屑病主动长期管理的益处及其良好的安全性在于更高的疗效和更好的健康相关生活质量。钙泊三醇/倍他米松泡沫剂应被视为成人银屑病患者短期发作治疗和长期控制的一种有效局部治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5a5/9075015/f8a98828e069/CCID-15-809-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5a5/9075015/7031d975007b/CCID-15-809-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5a5/9075015/f8a98828e069/CCID-15-809-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5a5/9075015/7031d975007b/CCID-15-809-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5a5/9075015/f8a98828e069/CCID-15-809-g0002.jpg

相似文献

1
Short Term and Long-Term Efficacy of Calcipotriene/ Betamethasone Dipropionate Foam Combination.卡泊三醇/倍他米松二丙酸酯泡沫组合的短期和长期疗效
Clin Cosmet Investig Dermatol. 2022 May 2;15:809-814. doi: 10.2147/CCID.S361884. eCollection 2022.
2
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).每周两次局部外用钙泊三醇倍他米松二丙酸酯泡沫作为斑块状银屑病的主动治疗,可增加缓解时间,52 周内耐受性良好(PSO-LONG 试验)。
J Am Acad Dermatol. 2021 May;84(5):1269-1277. doi: 10.1016/j.jaad.2020.09.037. Epub 2020 Sep 18.
3
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.Cal/BD 泡沫固定剂量联合治疗中进行主动或被动管理的银屑病患者的生活质量和患者感知症状:PSO-LONG 的事后分析。
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):60-67. doi: 10.1111/jdv.17673. Epub 2021 Oct 21.
4
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.卡泊三醇倍他米松二丙酸酯气雾剂泡沫剂与软膏剂治疗寻常型银屑病疗效对比——一项随机II期研究
J Dermatolog Treat. 2016;27(2):120-7. doi: 10.3109/09546634.2015.1083935. Epub 2015 Oct 7.
5
The role of the foam formulation in improving psoriasis treatment acceptability: a real-life experience and a literature review.泡沫制剂在改善银屑病治疗可接受性方面的作用:真实体验和文献复习。
Eur Rev Med Pharmacol Sci. 2023 Nov;27(21):10697-10704. doi: 10.26355/eurrev_202311_34350.
6
Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque Psoriasis.患者报告对用于斑块状银屑病的卡泊三醇/倍他米松二丙酸酯固定组合泡沫的满意度。
J Drugs Dermatol. 2018 Aug 1;17(8):880-884.
7
Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis.卡泊三醇 0.005%/倍他米松二丙酸酯 0.064%泡沫与卤倍他索 0.01%/他扎罗汀 0.045%乳剂治疗斑块状银屑病的有效性比较和增量成本-反应者分析:匹配调整的间接比较分析。
J Med Econ. 2020 Jun;23(6):641-649. doi: 10.1080/13696998.2020.1722139. Epub 2020 Mar 2.
8
Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study.患者对卡泊三醇倍他米松乳膏与泡沫剂治疗银屑病的偏好:一项初步研究。
J Drugs Dermatol. 2023 Mar 1;22(3):271-273. doi: 10.36849/JDD.7165.
9
Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience.卡泊三醇/倍他米松二丙酸酯气雾剂泡沫治疗银屑病:从真实经验看创新局部治疗药物的新用途。
G Ital Dermatol Venereol. 2020 Apr;155(2):212-219. doi: 10.23736/S0392-0488.20.06492-5.
10
PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis.PSO-LONG:一种新型的、为期 12 个月的局部主动维持治疗方案的设计,使用每周两次的钙泊三醇/倍他米松泡沫剂治疗银屑病。
Adv Ther. 2020 Nov;37(11):4730-4753. doi: 10.1007/s12325-020-01497-6. Epub 2020 Sep 23.

引用本文的文献

1
Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis.局部保湿剂、单独使用类固醇或与钙泊三醇联合使用对银屑病免疫浸润和临床结局的影响。
Exp Dermatol. 2022 Nov;31(11):1764-1778. doi: 10.1111/exd.14657. Epub 2022 Aug 19.

本文引用的文献

1
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.Cal/BD 泡沫固定剂量联合治疗中进行主动或被动管理的银屑病患者的生活质量和患者感知症状:PSO-LONG 的事后分析。
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):60-67. doi: 10.1111/jdv.17673. Epub 2021 Oct 21.
2
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis.在接受 HPA 轴检测的斑块型银屑病患者中,每周两次使用 Cal/BD 泡沫剂进行主动治疗的疗效和安全性:PSO-LONG 亚组分析。
J Dermatolog Treat. 2022 Jun;33(4):2297-2304. doi: 10.1080/09546634.2021.1959501. Epub 2021 Aug 9.
3
Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use.卡泊三醇/倍他米松二丙酸酯气雾剂泡沫用于斑块状银屑病:一项关于患者日常使用依从性和满意度的前瞻性、观察性、非干预性单中心研究。
Dermatol Pract Concept. 2021 May 20;11(3):e2021056. doi: 10.5826/dpc.1103a56. eCollection 2021 May.
4
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase).四周每日使用卡泊三醇倍他米松搽剂泡沫剂治疗银屑病患者具有显著疗效(PSO-LONG 导入期)。
J Drugs Dermatol. 2021 Apr 1;20(4):436-441. doi: 10.36849/JDD.2021.5728.
5
A real-world, observational study on the effectiveness with calcipotriol/betamethasone aerosol foam in patients with plaque psoriasis in Greece: the CELSUS study.一项关于卡泊三醇/倍他米松气雾剂泡沫对希腊斑块状银屑病患者有效性的真实世界观察性研究:CELSUS研究
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e454-e457. doi: 10.1111/jdv.17211. Epub 2021 Mar 25.
6
Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.固定剂量复方钙泊三醇/倍他米松二丙酸酯泡沫剂的早期疗效和安全性数据归因于吸收机制和类固醇效能。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):5-9. doi: 10.1111/jdv.17027.
7
Fixed-dose combination calcipotriol/betamethasone dipropionate foam provides a rapid onset of action, effective itch relief and improves patient quality of life.固定剂量复方卡泊三醇/倍他米松二丙酸酯泡沫起效迅速,能有效缓解瘙痒并改善患者生活质量。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):20-27. doi: 10.1111/jdv.17085.
8
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.应对银屑病患者长期局部治疗相关挑战及积极管理的益处。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):35-41. doi: 10.1111/jdv.17053.
9
General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach.银屑病局部治疗的一般实践建议:一种改良德尔菲法。
BJGP Open. 2020 Dec 15;4(5). doi: 10.3399/bjgpopen20X101108. Print 2020 Dec.
10
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).每周两次局部外用钙泊三醇倍他米松二丙酸酯泡沫作为斑块状银屑病的主动治疗,可增加缓解时间,52 周内耐受性良好(PSO-LONG 试验)。
J Am Acad Dermatol. 2021 May;84(5):1269-1277. doi: 10.1016/j.jaad.2020.09.037. Epub 2020 Sep 18.